Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies.

Yu, Yixuan; Zhou, Yang; Zhang, Xu; Tan, Kexin; Zheng, Jiabin; Li, Jia; Cui, Huijuan

Yu, Yixuan; Zhou, Yang; Zhang, Xu; Tan, Kexin; Zheng, Jiabin; Li, Jia; Cui, Huijuan.

Afiliação

Yu Y; Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Zhou Y; Oncology Department of Integrative Medicine, China-Japan Friendship Hospital, Beijing, China.
Zhang X; Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Tan K; Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Zheng J; Oncology Department of Integrative Medicine, China-Japan Friendship Hospital, Beijing, China.
Li J; Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Cui H; Oncology Department of Integrative Medicine, China-Japan Friendship Hospital, Beijing, China.

Front Oncol ; 12: 934093, 2022.

Article em En | MEDLINE | ID: mdl-35912183

Palavras-chave

autoimmune disease (AID); cytotoxic T lymphocyte-associated protein 4 (CTLA-4); immune checkpoint inhibitor (ICI); immune-related adverse event (irAE); programmed cell death 1 (PD-1); programmed cell death ligand 1 (PD-L1); psoriasis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Systematic_reviews Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google